Authors: SHROTRIYA RC CUTLER NR SRAMEK JJ VEROFF AE HIRONAKA DY

Citation: Rc. Shrotriya et al., EFFICACY AND SAFETY OF BMY-21,502 IN ALZHEIMER-DISEASE, The Annals of pharmacotherapy, 30(12), 1996, pp. 1376-1380

Authors: CUTLER NR VEROFF AE FRACKIEWICZ EJ WELKE TL KURTZ NM SRAMEK JJ

Citation: Nr. Cutler et al., ASSESSING THE NEUROPSYCHOLOGICAL PROFILE OF STABLE SCHIZOPHRENIC OUTPATIENTS, The Journal of neuropsychiatry and clinical neurosciences, 8(4), 1996, pp. 423-428

Authors: CUTLER NR VEROFF AE BODICK NC OFFEN WW SRAMEK JJ

Citation: Nr. Cutler et al., COGNITIVE IMPROVEMENT IN ALZHEIMERS-DISEASE - USE OF THE CNTB IN A TRIAL OF XANOMELINE, Biological psychiatry, 39(7), 1996, pp. 545-545

Authors: BRASS EP POLINSKY R SRAMEK JJ MOORE M JONES D VEROFF AE WARDLE TS CUTLER NR

Citation: Ep. Brass et al., EFFECTS OF THE CHOLINOMIMETIC SDZ ENS-163 ON SCOPOLAMINE-INDUCED COGNITIVE IMPAIRMENT IN HUMANS, Journal of clinical psychopharmacology, 15(1), 1995, pp. 58-62

Authors: SUDILOVSKY A CUTLER NR SRAMEK JJ WARDLE T VEROFF AE MICKELSON W MARKOWITZ J REPETTI S

Citation: A. Sudilovsky et al., A PILOT CLINICAL-TRIAL OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITORCERANAPRIL IN ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 7(2), 1993, pp. 105-111

Authors: FLEISHAKER JC SISSON TA SRAMEK JJ CONRAD J VEROFF AE CUTLER NR

Citation: Jc. Fleishaker et al., PSYCHOMOTOR AND MEMORY EFFECTS OF 2 ADINAZOLAM FORMULATIONS ASSESSED BY A COMPUTERIZED NEUROPSYCHOLOGICAL TEST BATTERY, Journal of clinical pharmacology, 33(5), 1993, pp. 463-469